While canonical TGF-β signaling is involved in both tumor-promoting and tumor-suppressive pathways, noncanonical TGF-β signaling especially activates tumor-promoting pathways that facilitate EMT and cell migration, such as the RAS/RAF/MEK/ERK pathway. The gene discussed is MAP2K7; the disease is neoplasm.